Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine
Abstract Ebola virus disease (EVD) outbreaks are increasing, posing significant threats to affected communities. Effective outbreak management depends on protecting frontline health workers, a key focus of EVD vaccination strategies. IgG specific to the viral glycoprotein serves as the correlate of...
Saved in:
| Main Authors: | Daniel O’Connor, Elizabeth A. Clutterbuck, Malick M. Gibani, Sagida Bibi, Katherine A. Sanders, Rebecca Makinson, Dominic F. Kelly, Andrew J. Pollard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61571-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A critical analysis of UK media characterisations of Long Covid in children and young people.
by: Chloe Connor, et al.
Published: (2024-01-01) -
Vaccines for Ebola
by: Editorial Article
Published: (2015-02-01) -
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
by: Igor Morozov, et al.
Published: (2021-01-01) -
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose
by: Christina A. Rostad, et al.
Published: (2024-12-01) -
Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study
by: Nayab Batool Rizvi, et al.
Published: (2024-11-01)